Medications for the treatment of Hepititus - Updated April, 2007
It should be understood that only a small percentage of people suffer debilitating side effects, and in most cases the side effects can be controlled if they know in advance what to expect if they should they occur. For information on where and how these medications work see T.A.S.K. lesson 2. For tips on managing side effects and adherence see T.A.S.K. lesson 3.

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)

Expanded Access means that the medication is in the final stages of approval by the FDA and is available to those failing on current medications. Your doctor or case manager can contact the company and enroll you it the Expanded Access Program. Expanded Access Programs stop taking new patients when medications are approved; however, they may be available through Patient Assistance Programs, once approved, for those who cannot afford the medication, do not have insurance and cannot qualify for other assistance programs. Click on "Finances" for more information on these programs.